Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2713-2720
Published online before print October 18, 2004, doi: 10.1161/01.CIR.0000146846.00816.DD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/17/2713    most recent
01.CIR.0000146846.00816.DDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khreiss, T.
Right arrow Articles by Filep, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khreiss, T.
Right arrow Articles by Filep, J. G.
Related Collections
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Arterial thrombosis
Right arrow Aggregation
Right arrow Acute coronary syndromes
Right arrow Platelets

(Circulation. 2004;110:2713-2720.)
© 2004 American Heart Association, Inc.


Vascular Medicine

Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood

Tarek Khreiss, MSc*; Levente József, MSc*; Lawrence A. Potempa, PhD; János G. Filep, MD

From the Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montreal, Montreal, Quebec, Canada (T.K., L.J., J.G.F.), and Immtech International, Inc (L.A.P.), Vernon Hills, Ill.

Correspondence to János G. Filep, MD, Research Center, Maisonneuve-Rosemont Hospital, 5415 boulevard de l’Assomption, Montreal, Quebec, Canada H1T 2M4. E-mail janos.g.filep{at}umontreal.ca

Received April 14, 2004; revision received July 20, 2004; accepted August 23, 2004.

Background— Plasma C-reactive protein (CRP) level is a powerful predictor of cardiovascular events. However, it is not known whether CRP could affect neutrophil-platelet adhesion and neutrophil aggregation, key events in acute coronary syndromes. Emerging in vitro evidence suggests that some bioactivities of CRP are expressed on loss of the pentameric symmetry, resulting in formation of modified or monomeric CRP (mCRP).

Methods and Results— We studied the impact of human native CRP and bioengineered mCRP that cannot rearrange into the pentameric structure on the kinetics of neutrophil-platelet adhesion and neutrophil aggregation in whole blood subjected to shear ({approx}100 s–1) using real-time flow cytometry. Shear resulted in upregulation of platelet P-selectin expression, leading to platelet capture of neutrophils and subsequent neutrophil aggregation, which was dependent on P-selectin, L-selectin, and CD18. Native CRP at clinically relevant concentrations markedly attenuated these changes. The residual amount of neutrophil adhesion was blocked with anti-CD18 or anti-CD11b antibody. By contrast, mCRP concentration-dependently enhanced shear-induced platelet P-selectin expression and increased the rate and extent of formation of both neutrophil-platelet and neutrophil-neutrophil aggregates. Complete abrogation of platelet-neutrophil adhesion and neutrophil aggregation required both anti-P-selectin and anti-CD18 antibodies but not anti-L-selectin antibody. The CRP action was markedly inhibited by an anti-CD32 antibody, whereas the mCRP effects were significantly attenuated by an anti-CD16 antibody.

Conclusions— These results indicate that native CRP inhibits platelet activation and prevents platelet capture of neutrophils, whereas mCRP displays potent prothrombotic activities under low levels of shear. Thus, mCRP rather than native CRP may precipitate acute coronary syndromes.


Key Words: neutrophils • platelets • cell adhesion molecules • inflammation • heart disease




This article has been cited by other articles:


Home page
FASEB J.Home page
S.-R. Ji, L. Ma, C.-J. Bai, J.-M. Shi, H.-Y. Li, L. A. Potempa, J. G. Filep, J. Zhao, and Y. Wu
Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains
FASEB J, June 1, 2009; 23(6): 1806 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Inforzato, V. Rivieccio, A. P. Morreale, A. Bastone, A. Salustri, L. Scarchilli, A. Verdoliva, S. Vincenti, G. Gallo, C. Chiapparino, et al.
Structural Characterization of PTX3 Disulfide Bond Network and Its Multimeric Status in Cumulus Matrix Organization
J. Biol. Chem., April 11, 2008; 283(15): 10147 - 10161.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Blaschke, Y. Takata, E. Caglayan, A. Collins, P. Tontonoz, W. A. Hsueh, and R. K. Tangirala
A Nuclear Receptor Corepressor-Dependent Pathway Mediates Suppression of Cytokine-Induced C-Reactive Protein Gene Expression by Liver X Receptor
Circ. Res., December 8, 2006; 99(12): e88 - e99.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation, May 2, 2006; 113(17): 2128 - 2151.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
I. Ciubotaru, L. A. Potempa, and R. C. Wander
Production of Modified C-Reactive Protein in U937-Derived Macrophages
Experimental Biology and Medicine, November 1, 2005; 230(10): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Trion, M.P.M. de Maat, J.W. Jukema, A. van der Laarse, M.C. Maas, E.H. Offerman, L.M. Havekes, A.J. Szalai, H.M.G. Princen, and J.J. Emeis
No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1635 - 1640.
[Abstract] [Full Text] [PDF]